About FastSense Innovations
FastSense Innovations is a company based in Pune (India) founded in 2023 by Preeti Nigam Joshi. It operates as a B2B. FastSense Innovations has raised $40.09 thousand across 1 funding round from investors including Entrepreneurship Development Institute of India. FastSense Innovations offers products and services including Nucleic Acid-Based Test Kits, Smartphone-Based Devices, Sepsis Prediction Model, Diagnostic Consultations, and Training Programs. FastSense Innovations operates in a competitive market with competitors including Omega Therapeutics, BiomeSense, BAMF Health, InpharmD and Coriell Life Sciences, among others.
- Headquarter Pune, India
- Founders Preeti Nigam Joshi
-
Sectors
TechnologyHealthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Fastsense Innovations Pvt. Ltd.
- Jurisdiction Pune, Maharashtra, India
-
Annual Revenue
$25.5 K (USD)0as on Mar 31, 2019
-
Net Profit
-$385.11 (USD)0as on Mar 31, 2019
-
EBITDA
-$24.41 K (USD)0as on Mar 31, 2019
-
Total Equity Funding
$40.09 K (USD)
in 1 rounds
-
Latest Funding Round
$40.09 K (USD), Seed
Feb 01, 2022
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of FastSense Innovations
FastSense Innovations offers a comprehensive portfolio of products and services, including Nucleic Acid-Based Test Kits, Smartphone-Based Devices, Sepsis Prediction Model, Diagnostic Consultations, and Training Programs.
Kits for accurate detection of viral RNA and DNA in healthcare settings.
Devices for on-the-spot analysis and rapid health metric monitoring.
Machine-learning tool for real-time sepsis monitoring and early warnings.
Expert advice on interpreting diagnostic results for informed decisions.
Programs to enhance skills in using diagnostic solutions effectively.
Funding Insights of FastSense Innovations
FastSense Innovations has successfully raised a total of $40.09K through 1 strategic funding round. The most recent funding activity was a Seed round of $40.09 thousand completed in February 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in FastSense Innovations
FastSense Innovations has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Entrepreneurship Development Institute of India.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked |
Investor details for FastSense Innovations
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by FastSense Innovations
Investment portfolio details for FastSense Innovations
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - FastSense Innovations
Detailed financials for FastSense Innovations
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Fastsense Innovations Comparisons
Peer comparison for FastSense Innovations
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of FastSense Innovations
FastSense Innovations operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Omega Therapeutics, BiomeSense, BAMF Health, InpharmD and Coriell Life Sciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Platform for human genome study is provided for precision medicine.
|
|
| Locked | Locked | Locked |
AI-enabled platform for microbiome data generation and analysis is developed.
|
|
| Locked | Locked | Locked |
AI-enabled molecular imaging and theranostics for disease diagnostics are developed.
|
|
| Locked | Locked | Locked |
Evidence-based drug information is provided to healthcare providers online.
|
|
| Locked | Locked | Locked |
Provider of precision medicine tools for clinicians
|
|
| Locked | Locked | Locked |
Storage, management and analysis of omic data for health applications
|
Detailed competitors of FastSense Innovations
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Fastsense Innovations
Complete news archive for FastSense Innovations
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about FastSense Innovations
FastSense Innovations was founded in 2023.
FastSense Innovations is headquartered in Pune, India. It is registered at Pune, Maharashtra, India.
FastSense Innovations is a funded company, having raised a total of $40.09K across 1 funding round to date.
Annual revenue of FastSense Innovations is $25.5K as on Mar 31, 2019.
FastSense Innovations creates advanced diagnostic solutions, including nucleic acid test kits and smartphone-based devices, to detect diseases like sepsis, hepatocellular carcinoma, and pancreatic cancer. Using AI and molecular biology, they provide precise, affordable tools for healthcare professionals globally. Based in Pune, India, the company offers services such as training, consultations, and predictive modeling to enhance early intervention and improve outcomes in various clinical settings.
FastSense Innovations's top competitors include Omega Therapeutics, CueZen and Coriell Life Sciences.
FastSense Innovations offers Nucleic Acid-Based Test Kits, Smartphone-Based Devices, Sepsis Prediction Model, Diagnostic Consultations, and Training Programs.
FastSense Innovations has 1 investor. Key investors include Entrepreneurship Development Institute of India.